CELL ADHESION MOLECULES IN OCULAR INFLAMMATION
CELL ADHESION MOLECULES IN OCULAR INFLAMMATION
批准号:
3856068
负责人:
S M WHITCUP
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cell adhesion molecules are surface proteins that mediate the binding of
cells to extracellular matrix and to other cells. The expression of cell
adhesion molecules, which is important for the migration of leukocytes to
sites of inflammation, and is partly regulated by the secretion of
cytokines. We are studying the expression of cell adhesion molecules in the
eye, in both animal models of ocular inflammation and human eyes with
uveitis.
Over the past year, we have demonstrated the expression of endothelial
leukocyte adhesion molecule 1 (ELAM-1) on the corneal endothelium in Lewis
rats with endotoxin-induced uveitis. Expression of ELAM-1 precedes the
binding of neutrophils and the formation of keratic precipitates. In human
eyes with posterior uveitis, we have shown that lymphocyte function-
associated antigen 1 (LFA-1) is expressed on lymphocytes infiltrating the
retina and choroid. Intercellular adhesion molecule 1 (ICAM-1), the
counter receptor for LFA-1, was demonstrated on retinal pigment epithelium,
on vascular endothelium, and on glial cells of the retina in areas of
inflammation. Increased levels of tumor necrosis factor, which were
demonstrated in eyes with uveitis, may play a role in the induction of
these adhesion molecules. We have also examined the expression of adhesion
molecules in eyes with intraocular lymphoma and demonstrated LFA-1 and
ICAM-1 on cells from an intraocular lymphoma in a patient with AIDS. In a
second intraocular lymphoma in a patient without AIDS, ICAM-1 but not LFA-1
was expressed on tumor cells. Expression of adhesion molecules on lymphoma
cells may be important for the localization of the tumor in the eye.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS
-
批准号:3777642
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
DIAGNOSIS AND TREATMENT OF AIDS RELATED OCULAR DISEASE
-
批准号:6162396
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS AND AIDS-RELATED OCULAR DISEASE
-
批准号:2574511
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
CELL ADHESION MOLECULES IN OCULAR INFLAMMATION
-
批准号:3777644
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS AND AIDS-RELATED OCULAR DISEASE
-
批准号:3755574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
IMMUNOLOGIC MECHANISMS OF OCULAR DISEASE
-
批准号:2574512
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
CELL ADHESION MOLECULES IN OCULAR INFLAMMATION
-
批准号:3841243
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
OCULAR TOXICITY OF 2',3'-DIDEOXYINOSINE
-
批准号:3755575
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
DIAGNOSIS AND TREATMENT OF OCULAR INFLAMMATORY DISEASE
-
批准号:6162369
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
OCULAR TOXICITY OF 2',3'-DIDEOXYINOSINE
-
批准号:3841242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
THE DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS
-
批准号:3856066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS AND AIDS-RELATED OCULAR DISEASE
-
批准号:5202335
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
IMMUNOLOGIC MECHANISMS OF OCULAR DISEASE
-
批准号:5202336
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
IMMUNOLOGIC MECHANISMS OF OCULAR DISEASE
-
批准号:3755576
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
OCULAR TOXICITY OF 2',3'-DIDEOXYINOSINE
-
批准号:3777643
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
THE DIAGNOSIS AND TREATMENT OF HUMAN UVEITIS
-
批准号:3841241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
OCULAR TOXICITY OF 2',3'-DIDEOXYINOSINE
-
批准号:3856067
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M WHITCUP
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: